Informações:
Falhas:
ID
12769
Descrição
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00385996
Link
https://clinicaltrials.gov/show/NCT00385996
Palavras-chave
Versões (1)
- 21/12/2015 21/12/2015 -
Transferido a
21 de dezembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Carcinoma, Non-small Cell Lung NCT00385996
Eligibility Carcinoma, Non-small Cell Lung NCT00385996
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-small Cell Lung NCT00385996
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Small Cell Lung Carcinoma; Excision
Item
biopsy proven stage i/ii non-small cell lung cancer who are candidates for surgical resection
boolean
C0007131 (UMLS CUI [1])
C0728940 (UMLS CUI [2])
C0728940 (UMLS CUI [2])
self-care; ambulatory
Item
ambulatory and capable of all self-care but may be unable to carry out any work activities.
boolean
C3639376 (UMLS CUI [1])
C1550332 (UMLS CUI [2])
C1550332 (UMLS CUI [2])
ct scans preoperative postoperative
Item
preoperative and postoperative high resolution ct scans done at nyph-weill cornell medical center for purposes of volumetric measurements.
boolean
C0040405 (UMLS CUI [1,1])
C0445204 (UMLS CUI [1,2])
C0205903 (UMLS CUI [1,3])
C0445204 (UMLS CUI [1,2])
C0205903 (UMLS CUI [1,3])
Cardiac function normal
Item
acceptable cardiac, breathing, kidney, liver, and bone marrow functions.
boolean
C0232164 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,2])
age
Item
18 years and older.
boolean
C0001779 (UMLS CUI [1])
pregnancy; Contraceptive methods
Item
women of child-bearing potential must be taking adequate contraceptive precautions prior to study entry and for the duration of study participation. a negative serum or urine pregnancy test is required within 7-10 days of tarceva® administration. men and premenopausal women of child bearing potential will follow an approved, medically accepted birth control regimen or agree to abstain from heterosexual intercourse while taking study drug and for 30 days following the last dose of study drug.
boolean
C0549206 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
Study Subject Participation Status
Item
cannot be on any other anti-cancer treatment during this study.
boolean
C2348568 (UMLS CUI [1])
Epidermal growth factor receptor inhibitor
Item
prior treatment with any egfr inhibitor.
boolean
C1443775 (UMLS CUI [1])
chemotherapy; radiotherapy
Item
patients who had prior treatment with chemotherapy or radiation for this disease.
boolean
C0392920 (UMLS CUI [1])
C0034619 (UMLS CUI [2])
C0034619 (UMLS CUI [2])
active cancer
Item
other active cancers.
boolean
C0006826 (UMLS CUI [1])
comorbidity Lung Neoplasms
Item
tumors with a mixed histology of small cell and non-small cell carcinoma as well as patients with pulmonary carcinoid tumors.
boolean
C0009488 (UMLS CUI [1,1])
C0024121 (UMLS CUI [1,2])
C0024121 (UMLS CUI [1,2])
comorbidity Gastrointestinal Diseases
Item
gastro-intestinal abnormalities, including active peptic ulcer or inflammatory bowel disease.
boolean
C0009488 (UMLS CUI [1,1])
C0017178 (UMLS CUI [1,2])
C0017178 (UMLS CUI [1,2])
hypersensitivity tarceva
Item
hypersensitivity to compounds similar in chemical composition to tarceva®.
boolean
C0020517 (UMLS CUI [1,1])
C1135136 (UMLS CUI [1,2])
C1135136 (UMLS CUI [1,2])
Compliance behavior limited comorbidity
Item
active infection or serious underlying medical conditions which would impair protocol treatment.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])